<?xml version="1.0" encoding="UTF-8"?>
<p id="Par12">In total, 80,977 participants were included in the 76 studies. The prevalence of DENV infection varied widely depending on clinical presentation and biomarkers of infection considered (Table 
 <xref rid="Tab1" ref-type="table">1</xref>). The IgG seroprevalence in febrile participants was 24.8% (95%CI 13.8–37.8) and 15.6% (95%CI 9.9–22.2) in apparently healthy individuals without significant difference (
 <italic>p</italic> = 0.165) (Fig. 
 <xref rid="Fig2" ref-type="fig">2</xref>; Table 
 <xref rid="Tab1" ref-type="table">1</xref>). Sensitivity analysis considering only study with DENV infection confirmation by PNRT test yielded findings in the range of that of crude analysis (Table 
 <xref rid="Tab1" ref-type="table">1</xref>).
</p>
